Advertisement
Advertisement
KYNB
K
Kyntra Bio, Inc. Common Stock
7.14
USDSponsored
+0.13
+1.84%
Apr 24, 16:00 UTC -4
Closed
After-Market
7.08
-0.05
-0.77%
KYNB Earnings Reports
Positive Surprise Ratio
KYNB beat 2 of 2 last estimates.
100%
Next Report
Date of Next Report
May 11, 2026
Estimate for Q1 26 (Revenue/ EPS)
$1.34M
/-$3.42
Implied change from Q4 25 (Revenue/ EPS)
+4.55%
/-5.26%
Implied change from Q1 25 (Revenue/ EPS)
--
/-373.60%
Kyntra Bio, Inc. Common Stock earnings per share and revenue
On Mar 16, 2026, KYNB reported earnings of -3.61 USD per share (EPS) for Q4 25, beating the estimate of -3.96 USD, resulting in a 8.90% surprise. Revenue reached 1.28 million, compared to an expected 1.45 million, with a -12.07% difference. The market reacted with a +5.29% price change (close before vs. close after earnings).
Looking ahead to Q1 26, -- analysts forecast an EPS of -3.42 USD, with revenue projected to reach 1.34 million USD, implying an decrease of -5.26% EPS, and increase of 4.55% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Lexaria Bioscience Corp. Common Stock
Report Date
Apr 13, 2026 For Q2 26
Estimate
-$0.09
Actual
-$0.06
Surprise
+38.08%
GeoVax Labs, Inc. New
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$6.29
Actual
$0.00
Surprise
+99.92%
KALA BIO, Inc. Common Stock
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$1.46
Actual
-$0.67
Surprise
+54.38%
FAQ
What were Kyntra Bio, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Kyntra Bio, Inc. Common Stock reported EPS of -$3.61, beating estimates by 8.9%, and revenue of $1.28M, -12.07% below expectations.
How did the market react to Kyntra Bio, Inc. Common Stock's Q4 2025 earnings?
The stock price moved up 5.29%, changed from $7.00 before the earnings release to $7.37 the day after.
When is Kyntra Bio, Inc. Common Stock expected to report next?
The next earning report is scheduled for May 11, 2026.
What are the forecasts for Kyntra Bio, Inc. Common Stock's next earnings report?
Based on --
analysts, Kyntra Bio, Inc. Common Stock is expected to report EPS of -$3.42 and revenue of $1.34M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement